NCT06572371

Brief Summary

To prospectively compare the perioperative, morphological and functional outcomes on short and medium term between laparoscopic (LP) and open pyeloplasty (OP) patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 27, 2024

Completed
Last Updated

August 27, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

August 22, 2024

Last Update Submit

August 24, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Amount of blood loss

    Amount of blood loss was recorded.

    Intraoperatively

Secondary Outcomes (2)

  • Etiology of obstruction

    Intraoperatively

  • Complications

    24 hours postoperatively

Study Arms (2)

Laparoscopic pyeloplasty

EXPERIMENTAL

Patients underwent laparoscopic pyeloplasty.

Procedure: Laparoscopic pyeloplasty

Open pyeloplasty

ACTIVE COMPARATOR

Patients underwent open pyeloplasty.

Procedure: Open pyeloplasty

Interventions

The first trocar was inserted under vision through the same supraumbilical incision and the intraperitoneal cavity was inspected The second 5 mm trocar was placed in the midclavicular line 2 inches below the costal margin. The third 10 mm trocar was placed lateral to the rectus muscle at the level of the anterior superior iliac spine. In right-sided pyeloplasty, a fourth trocar was inserted below the xiphistemum for liver retraction. Incision of the line of Toldt and mobilization of the colon was the first step of the transperitoneal approach. A 4/0 polysorbe stay suture was taken in the lateral aspect of the ureter distal to uretero-pelvic junction obstruction to identify the correct orientation after dismembering the ureter. A full thickness anastomosis was started from the angle of V shape spatulation to the lower pole of the renal pelvis.

Laparoscopic pyeloplasty

A flank incision with the patient in lateral position was undertaken in open pyeloplasty. After accessing the retro- peritoneum, the ureter was identified and traced cranially till the PUJ segment. Traction sutures was placed on the renal pelvis followed by excision of the narrowing segment. The ureter was spatulated by approximately 2 cm and a reduction pyeloplasty was performed, where necessary. Anastomosis was undertaken using vicryl 4-0 sutures. The primary anastomotic site was sutured in interrupted fashion followed by a continuous running suture of the posterior wall. Next, antegrade DJ stenting was performed and the anterior wall was anastomosed. After haemostatic control a 22 Fr drain was placed in the surgical bed.

Open pyeloplasty

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult patients (above 18 years old) with primary pelvi-ureteric junction obstruction indicated for active intervention as
  • Symptoms such as recurrent flank pain, recurrent urinary tract infection and rarely hypertension.
  • Breakthrough urinary tract infections while on prophylactic antibiotics.
  • Increasing renal antero-posterior diameter, or decreasing renal parenchymal thickness by ultrasound.
  • Low or decreasing differential renal function, but above 10%.

You may not qualify if:

  • Patients having poor ipsilateral renal function \< 10%.
  • Patients with previous pelvi-ureteric junction obstruction repair.
  • Associated renal stones.
  • Patients unfit for surgery according to American Society of Anesthesiologists classification.
  • Contraindications for laparoscopy as (marked obesity, large ventral hernias, gross coagulopathy, abdominal wall sepsis, vertebral deformities…).
  • Pediatric patients.
  • Pregnant women.
  • Vesicoureteral reflux.
  • Congenital renal anomalies as (horse- shoe kidney, pelvic kidney, mal- rotated kidney ...).
  • Single functioning kidney.
  • Malignancy.
  • Refusal of written consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, ElGharbia, 31527, Egypt

Location

MeSH Terms

Conditions

Bites and Stings

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.

Study Record Dates

First Submitted

August 22, 2024

First Posted

August 27, 2024

Study Start

October 1, 2022

Primary Completion

October 1, 2023

Study Completion

October 1, 2023

Last Updated

August 27, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

The data was available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data was available upon a reasonable request from the corresponding author.

Locations